Tindamax

Tindamax is a brand name of tinidazole, approved by the FDA in the following formulation(s):

TINDAMAX (tinidazole - tablet; oral)

• 
  Manufacturer: MISSION PHARMA
  
  Approval date: May 17, 2004
  
  Strength(s): 250MG, 500MG ^[RLD]

Has a generic version of Tindamax been approved?

No. There is currently no therapeutically equivalent version of Tindamax available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tindamax. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Tindamax.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • May 17, 2011 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Tindamax Consumer Information (Drugs.com)
• Tindamax Consumer Information (Wolters Kluwer)
• Tindamax Consumer Information (Cerner Multum)
• Tindamax Advanced Consumer Information (Micromedex)
• Tindamax AHFS DI Monographs (ASHP)
• Tinidazole Consumer Information (Wolters Kluwer)
• Tinidazole Consumer Information (Cerner Multum)
• Tinidazole Advanced Consumer Information (Micromedex)
• Tinidazole AHFS DI Monographs (ASHP)